Omada Health (OMDA) — Financial statements
Income statement, balance sheet, and cash flow for Omada Health — annual and quarterly history with growth and margin analysis.
| Metric (USD Millions) | 2025 | 2024 | 2023 | 2022 | |
|---|---|---|---|---|---|
| Revenue & Gross Profit | |||||
| Revenue | 260↑53.2% | 170↑38.3% | 123↑37.7% | 89 | |
| Cost of Revenue | 89↑33.4% | 67↑26.7% | 53↑13.8% | 46 | |
| Gross Profit | 171↑66.2% | 103↑47.0% | 70↑63.5% | 43 | |
| Operating Expenses | |||||
| R&D Expenses | 41↑13.3% | 36↑6.5% | 34↑28.9% | 26 | |
| General & Administrative Expenses | 52↑22.6% | 43↑18.3% | 36↑18.0% | 30 | |
| Selling & Marketing Expenses | 90↑32.3% | 68↑2.7% | 66↑13.3% | 58 | |
| SG&A Expenses | 142↑28.6% | 111↑8.2% | 102↑14.9% | 89 | |
| Other Expenses | 0.00 | 0.00 | 0.00 | 0.00 | |
| Operating Expenses | 183↑24.8% | 147↑7.8% | 136↑18.1% | 115 | |
| Total Costs & Expenses | 272↑27.5% | 213↑13.1% | 189↑16.9% | 162 | |
| Operating Results | |||||
| Operating Income | -12↑72.6% | -44↑33.9% | -66↑8.8% | -72 | |
| Depreciation & Amortization | 5↑14.3% | 5↑8.0% | 4↑2.7% | 4 | |
| EBITDA | -5↑87.4% | -38↑35.2% | -58↑8.8% | -64 | |
| EBIT | -10↑76.0% | -43↑32.1% | -63↑8.1% | -68 | |
| Interest & Other Income | |||||
| Net Interest Income | 3↑174.9% | -4↓445.9% | 1↑153.5% | -2 | |
| Interest Income | 5↑559.0% | 0.81↓86.1% | 6↑162.3% | 2 | |
| Interest Expense | 3↓43.8% | 5↓4.2% | 5↑12.0% | 4 | |
| Non-Operating Income | -2↓68.9% | -1↑67.9% | -3↑20.9% | -4 | |
| Other Income / Expenses | -0.81↑76.9% | -3↓130.1% | -2↓801.2% | -0.17 | |
| Income Before Tax | -13↑72.9% | -47↑30.2% | -68↑6.9% | -73 | |
| Income Tax Expense | 0.00 | 0.00 | 0.00 | 0.00 | |
| Net Income & EPS | |||||
| Net Income from Continuing Operations | -13↑72.9% | -47↑30.2% | -68↑6.9% | -73 | |
| Net Income from Discontinued Operations | 0.00 | 0.00 | 0.00 | 0.00 | |
| Net Income | -13↑72.9% | -47↑30.2% | -68↑6.9% | -73 | |
| Bottom-Line Net Income | -13↑72.9% | -47↑30.2% | -68↑6.9% | -73 | |
| EPS (Basic) | -0.22↑74.1% | -0.85↑29.8% | -1.21↑6.9% | -1.30 | |
| EPS (Diluted) | -0.22↑74.1% | -0.85↑29.8% | -1.21↑6.9% | -1.30 | |
| Weighted Average Shares | 58↑4.8% | 56↑0.0% | 56↑0.0% | 56 | |
| Weighted Average Diluted Shares | 58↑4.8% | 56↑0.0% | 56↑0.0% | 56 | |
* All figures in Millions of USD, except per share data. Growth rates calculated Year-over-Year (YoY). Data source: SEC Filings.